175 results on '"Karttunen TJ"'
Search Results
2. Nutritional Status in Young Adults with Screen-Detected Silent/Subclinical Coeliac Disease
- Author
-
Haapalahti, M., primary, Kulmala, P., additional, Karttunen, TJ., additional, Paajanen, L., additional, Laurila, K., additional, Mäki, M., additional, Mykkänen, H., additional, and Kokkonen, J., additional
- Full Text
- View/download PDF
3. Intestinal cytokine mRNA expression in delayed-type cow's milk allergy
- Author
-
Paajanen, L, Kokkonen, J, Karttunen, TJ, Tuure, T, Korpela, R, Vaarala, Outi, Paajanen, L, Kokkonen, J, Karttunen, TJ, Tuure, T, Korpela, R, and Vaarala, Outi
- Abstract
OBJECTIVES: The aim of the study was to investigate the characteristics of intestinal immune activation (ie, a chemokine receptor and cytokine expression profile) in delayed-type cow's milk allergy (CMA) appearing in the form of gastrointestinal symptoms. PATIENTS AND METHODS: In all biopsy samples taken from the duodenum and/or the terminal ileum, 30 were studied for the expression of interferon-gamma, transforming growth factor-beta, chemokine receptor (CCR)-4, CCR-5, IL-2, IL-6, IL-10, IL-12p35, IL-12p40 and IL-18 specific mRNA by real-time quantitative reverse transcriptase-polymerase chain reaction in 26 children ages 3 to 15 years: 10 with untreated delayed-type CMA, 6 with celiac disease (CD) and 10 controls. RESULTS: The children with delayed-type CMA showed lower IL-2 and IL-18 mRNA expression in the duodenum (both P = 0.055) and higher CCR-4 and IL-6 mRNA expression in the terminal ileum (P = 0.055, P = 0.016) compared with the controls. The children with CD exhibited slightly higher expression of interferon-gamma and CCR-4 mRNA (P = 0.054, P = 0.053) and lower expression of IL-18 mRNA (P = 0.004) in the duodenal samples compared with the controls. The mRNA expression levels of regulatory cytokines, transforming growth factor-beta and IL-10 remained similar in all 3 groups. CONCLUSIONS: The children with delayed-type gastrointestinal CMA showed a unique pattern of local intestinal hypersensitivity with Th2 response-related characteristics, a profile differing clearly from the children with CD. © 2006 Lippincott Williams & Wilkins, Inc.
- Published
- 2006
- Full Text
- View/download PDF
4. Heat shock protein expression is low in intestinal mucosa in juvenile idiopathic arthritis: a defect in immunoregulation?
- Author
-
Arvonen, M, primary, Tikanmäki, M, additional, Vähäsalo, P, additional, and Karttunen, TJ, additional
- Published
- 2010
- Full Text
- View/download PDF
5. Effect of heat denaturation on beta-lactoglobulin-induced gastrointestinal sensitization in rats : denatured betaLG induces a more intensive local immunologic response than native betaLG
- Author
-
Rytkonen, J, Karttunen, TJ, Karttunen, R, Valkonen, KH, Jenmalm, Maria, Alatossava, T, Björkstén, B, Kokkonen, J, Rytkonen, J, Karttunen, TJ, Karttunen, R, Valkonen, KH, Jenmalm, Maria, Alatossava, T, Björkstén, B, and Kokkonen, J
- Abstract
Beta-lactoglobulin (▀LG) is one of the first foreign antigens encountered by a newborn child, and it is the major allergen causing cow's milk allergy. Heat denaturation causes changes to the protein structure, but the significance of heat-induced changes for immunogenicity or allergenicity is not known. To clarify how heat denaturation affects allergenicity and immunogenicity, we immunized Hooded-Lister rat pups with intra-peritoneal injections of native or heat-denatured ▀LG at days 43 and 62 after birth. The animals were then fed native and denatured milk products twice weekly from 73 to 101 days of age with a feeding tube, after which they were allowed cheese and milk ad libitum, until they were killed on day 131. Total immunoglobulin (Ig)E and ▀LG-specific IgG1 and IgG2a levels were determined from serum samples. Spontaneous interleukin-4 (IL-4) and interferon-? (IFN-?) production was measured from duodenal specimens, and specimens of gastrointestinal mucosae were studied for the presence of inflammatory cells. The rats immunized with native ▀LG had higher levels of total serum IgE than the unimmunized controls or the rats immunized with heat-denatured ▀LG, while heat-denatured ▀LG induced a significantly more intensive mononuclear inflammatory cell and eosinophil infiltration in the gastroduodenal mucosa. The ▀LG -specific IgG antibody and IL-4 and IFN-? responses were similar in the two groups of immunized animals. Hence, denaturation modifies the immunogenic and allergenic properties of ▀LG. Heat-denatured ▀LG induces a more intensive local reaction in the gastrointestinal mucosa, while there is some evidence for enhanced systemic allergic sensitization by native ▀LG. ⌐ 2002 Blackwell Munksgaard.
- Published
- 2002
- Full Text
- View/download PDF
6. Mucosal pathology of the foregut associated with food allergy and recurrent abdominal pains in children
- Author
-
Kokkonen, J, primary, Ruuska, T, additional, Karttunen, TJ, additional, and Niinimäki, A, additional
- Published
- 2007
- Full Text
- View/download PDF
7. Enhanced local immune response in children with prolonged gastrointestinal symptoms
- Author
-
Kokkonen, J, primary, Holm, K, additional, Karttunen, TJ, additional, and Mäki, M, additional
- Published
- 2004
- Full Text
- View/download PDF
8. Serum and Tissue CD23, IL-15, and FasL in Cow's-Milk Protein-sensitive Enteropathy and in Coeliac Disease.
- Author
-
Kokkonen TS, Augustin MT, Kokkonen J, Karttunen R, and Karttunen TJ
- Published
- 2012
9. Human leucocyte antigen and TNFalpha polymorphism association in microscopic colitis.
- Author
-
Koskela RM, Karttunen TJ, Niemela SE, Lehtola JK, Ilonen J, and Karttunen RA
- Published
- 2008
- Full Text
- View/download PDF
10. Budding invasive margin and prognosis in colorectal cancer - no direct association with beta-catenin expression.
- Author
-
Hörkkö TT, Klintrup K, Mäkinen JM, Näpänkangas JB, Tuominen HJ, Mäkelä J, Karttunen TJ, and Mäkinen MJ
- Abstract
Cancer cell budding at the invasive margin has been associated with poor prognosis in rectal cancer. beta-Catenin is an adhesion protein involved in the nuclear Wnt/beta-catenin pathway, and mesenchymal transition of colorectal cancer cells. Hence, we investigated the relationship between cancer cell budding at the invasive margin, beta-catenin expression, and 5-year-survival in colorectal cancer. Four hundred and sixty six colorectal cancer specimens were analysed for budding margin, and 108 specimens from the same set for beta-catenin by immunohistochemistry. A budding margin was present in 24.0% of the cases and predicted a poor 5-year-survival (15.4%, P<0.00001). Nuclear beta-catenin expression increased from the central area towards the invasive margin (P<0.001), but did not predict budding. Budding margin is an independent factor associated with poor prognosis in colorectal cancer, and could be utilised in diagnostic pathology. Nuclear beta-catenin was often found at the invasive margin, but is unlikely to be the sole cause of budding. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
11. Histological synovitis score in juvenile idiopathic arthritis and other pediatric synovial inflammatory conditions.
- Author
-
Päkkilä TS, Seppälä TS, Vähäsalo P, and Karttunen TJ
- Subjects
- Humans, Child, Female, Male, Adolescent, Child, Preschool, Severity of Illness Index, Infant, Arthritis, Juvenile pathology, Arthritis, Juvenile diagnosis, Synovitis pathology, Synovitis diagnosis, Synovial Membrane pathology
- Abstract
Objective: The Krenn's scoring is a system for histopathological grading of synovial inflammation, and in adults, useful in etiological grouping. The score has only rarely been used in pediatric samples. We aimed to assess the performance of the score in juvenile idiopathic arthritis and other pediatric synovial inflammatory processes in categorization of the disease and in finding characteristic pathological features., Design: We collected an unselected series of pediatric (age < 16 years) routine synovial biopsy samples to represent normal synovium and inflammatory conditions. The final diagnosis based on clinical follow-up was determined and classified as normal synovium, and different groups according to etiology. Total of 142 patients were analyzed. According to the score, case was classified to normal, low- or high-grade synovitis., Results: The synovitis scores in clinically normal synovium were low with 48 % of cases with scores of low-grade synovitis. In structural joint disorders scores varied from normal to low grade synovitis with occasional cases of high grade synovitis. In transient/reactive arthritis scores showed increase, majority clustering to low grade synovitis. In JIA and in bacterial synovitis the scores were higher than in the other groups high grade synovitis being the dominant grade. Extended oligoarthritis showed higher score than persistent oligoarthritis. ROC analysis indicated that JIA could be differentiated from other conditions., Conclusions: The Krenn's synovitis score is useful in the etiological classification of pediatric synovial samples, high Krenn's score suggesting JIA. Observed differences between the subcategories of oligoarthritis may be useful in subclassifying these types of JIA., Competing Interests: Declaration of Competing Interest There is no conflict of interest, (Copyright © 2024 The Authors. Published by Elsevier GmbH.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
12. Dynamics of adipose tissue macrophage populations after gastric bypass surgery.
- Author
-
Palomäki VA, Lehenkari P, Meriläinen S, Karttunen TJ, and Koivukangas V
- Subjects
- Humans, Case-Control Studies, Obesity surgery, Obesity complications, Adipose Tissue surgery, Weight Loss, Macrophages, Gastric Bypass, Obesity, Morbid surgery, Obesity, Morbid complications
- Abstract
Objective: This case-control study aimed to analyze the dynamics of macrophage infiltration in subcutaneous adipose tissue following bariatric surgery or conservative treatment of obesity and to clarify whether these features predict the weight loss outcome after the surgery., Methods: Subcutaneous tissue samples taken before and 12 months after laparoscopic Roux-en-Y gastric bypass surgery (n = 39) or conservative (n = 43) treatment for obesity were analyzed. Fat cell size was determined, and with CD68 immunohistochemistry, crown-like structures (CLS) were counted and single macrophages were quantitated., Results: A major decline in CLS density from 4.1 (SD 3.5) to 1.1 (SD 0.8) per 1000 fat cells (p < 0.000) was found, regardless of the degree of weight loss after the surgery. Surgery had no effect on the fraction of infiltrating single-cell macrophages in subcutaneous adipose tissue. The abundance of these macrophage populations before the intervention did not predict the degree of postsurgery weight loss or suboptimal response to the surgery., Conclusions: The effect of gastric bypass on adipose tissue inflammatory status associates closely with CLS density even in subjects with suboptimal weight loss. The study suggests that factors related to bypass surgery other than weight loss modify the inflammatory response in adipose tissue., (© 2022 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society.)
- Published
- 2023
- Full Text
- View/download PDF
13. Putative anoikis resistant subpopulations are enriched in lymph node metastases and indicate adverse prognosis in colorectal carcinoma.
- Author
-
Mattila TT, Patankar M, Väyrynen JP, Klintrup K, Mäkelä J, Tuomisto A, Nieminen P, Mäkinen MJ, and Karttunen TJ
- Subjects
- Humans, Lymphatic Metastasis, Prognosis, Lymph Nodes pathology, Anoikis, Colorectal Neoplasms pathology
- Abstract
Anoikis refers to apoptosis induced by the loss of contact with the extracellular matrix. Anoikis resistance is essential for metastasis. We have recently shown that it is possible to quantitatively evaluate putative anoikis resistant (AR) subpopulations in colorectal carcinoma (CRC). Abundance of these multi-cell structures is an independent marker of adverse prognosis. Here, we have quantified putative AR subpopulations in lymph node (LN) metastases of CRC and evaluated their prognostic value and relationship with the characteristics of primary tumors. A case series included 137 unselected CRC patients, 54 with LN metastases. Areal densities (structures/mm
2 ) of putative AR structures in primary tumors had been analyzed previously and now were determined from all nodal metastases (n = 183). Areal density of putative AR structures was higher in LN metastases than in primary tumors. Variation of the areal density within different LN metastases of a single patient was lower than between metastases of different patients. Abundance of putative AR structures in LN metastases was associated with shorter cancer specific survival (p = 0.013), and this association was independent of T and N stages. Abundance of putative AR structures in primary tumors and LN metastases had a cumulative adverse effect on prognosis. Enrichment of putative AR subpopulations in LN metastases suggest that in metastasis formation, there is a selection favoring cells capable of forming these structures. Higher intra-case constancy relative to inter-case variation suggests that such selection is stable in metastasis development. Our findings indirectly support the biological validity of our concept of putative AR structures., (© 2022. The Author(s).)- Published
- 2022
- Full Text
- View/download PDF
14. A Straightforward Method for Adipocyte Size and Count Analysis Using Open-source Software QuPath.
- Author
-
Palomäki VA, Koivukangas V, Meriläinen S, Lehenkari P, and Karttunen TJ
- Subjects
- Adipocytes metabolism, Adipose Tissue metabolism, Humans, Obesity metabolism, Software, Diabetes Mellitus, Type 2 pathology
- Abstract
Changes in adipose tissue morphology, depicted by cell morphology alterations such as enlargement of fat cells, always accompany over-weight and obesity. The variables related to cell size have been shown to associate with low-grade inflammation of adipose tissue and common obesity-related comorbidities including metabolic syndrome and type 2 diabetes. Quantifying fat cell morphology from images of histological specimens can be tedious. Here, we present a straightforward method for the task using the free open-source software QuPath with its inbuilt tools only. Measurements of human adipose tissue samples with the described protocol showed an excellent correlation with those obtained with ImageJ software with Adipocyte Tools plugin combined with manual correction of misdetections. Intraclass correlation between the two methods was at good to excellent level. The method described here can be applied to considerably large tissue areas, even whole-slide analysis.
- Published
- 2022
- Full Text
- View/download PDF
15. TLR2 and TLR4 in colorectal cancer: relationship to tumor necrosis and markers of systemic inflammation.
- Author
-
Paarnio K, Väyrynen JP, Väyrynen SA, Kantola T, Karhu T, Tervahartiala T, Klintrup K, Sorsa T, Salo T, Mäkelä J, and Karttunen TJ
- Subjects
- Humans, Interleukin-6 metabolism, Toll-Like Receptor 4 metabolism, Matrix Metalloproteinase 8, Interleukin-8, Inflammation, Necrosis, Systemic Inflammatory Response Syndrome, Tumor Necrosis Factor-alpha, Toll-Like Receptor 2 metabolism, Colorectal Neoplasms metabolism
- Abstract
In colorectal cancer (CRC), systemic inflammation is associated with poor prognosis, but the underlying mechanisms are not fully characterized. Tumor necrosis may contribute to systemic inflammation by inducing interleukin (IL)-6 signaling, and proinflammatory cytokines such as IL-6 and IL-8, and matrix metalloproteinase (MMP)-8 also are linked to adverse CRC outcomes. Because Toll-like receptors (TLRs) are important mediators of inflammatory responses, we investigated the roles of TLR2 and TLR4 in CRC-associated systemic inflammatory responses, especially tumor necrosis. In 118 patients with CRC, extensive tumor necrosis was associated with low TLR4 expression in tumor cells. Tumor cell TLR4 expression was inversely correlated with serum IL-6 and MMP-8 levels, blood total leukocyte and neutrophil counts, and serum C-reactive protein levels. Tumor cell TLR2 expression was not significantly associated with necrosis or systemic inflammation, but low expression in normal mucosa was linked to high serum MMP-8 and IL-8. These findings indicate that tumor necrosis is associated with low TLR4 expression in cancer cells and that low TLR4 expression correlates with a strong systemic inflammatory response. The low TLR2 expression in normal mucosa and its association with systemic inflammation suggest that the normal mucosa may reflect or contribute to the systemic inflammatory response.
- Published
- 2022
- Full Text
- View/download PDF
16. Predictive value of p53, Ki67 and TLR5 in neoplastic progression of Barrett's esophagus: a matched case-control study.
- Author
-
Helminen O, Melkko J, Saarnio J, Sihvo E, Kuopio T, Ohtonen P, Kauppila JH, Karttunen TJ, and Huhta H
- Subjects
- Case-Control Studies, Humans, Ki-67 Antigen metabolism, Metaplasia, Retrospective Studies, Toll-Like Receptor 5 metabolism, Tumor Suppressor Protein p53, Adenocarcinoma pathology, Barrett Esophagus pathology, Esophageal Neoplasms pathology
- Abstract
Barrett's esophagus progresses to high-grade dysplasia or cancer along the well-established metaplasia-dysplasia-adenocarcinoma sequence. The aim of this study was to evaluate the value of p53, Ki67, and toll-like receptor 5 (TLR5) in prediction of malignant progression of Barrett's metaplasia and low-grade dysplasia. This was a retrospective matched case-control study based on Northern and Central Finland population. Patients diagnosed with esophageal high-grade dysplasia or adenocarcinoma were included. From these patients, all previous endoscopy samples were obtained along with original diagnostic HE-slides and clinical data. Age- and sex-matched patients with non-progressing Barrett's metaplasia and low-grade dysplasia confirmed with follow-up endoscopies were used as controls. Two gastrointestinal pathologist re-reviewed all original HE-slides, and newly made sections to confirm representative tissue material blinded from clinical data. p53, Ki67, and TLR5 were immunohistochemically stained. Final cohort included 45 patients with progressive Barrett's metaplasia (n = 21) or low-grade dysplasia (n = 24), and 92 patients with non-progressive Barrett's metaplasia (n = 52) or low-grade dysplasia (n = 40). In Barrett's metaplasia, aberrant p53 expression was observed in 6% of samples in progressors and 0% in non-progressors. In low-grade dysplasia, aberrant p53 was seen in 56% of samples in progressors and 17% in non-progressors (Odd's ratio 6.7, 95% CI 1.8-24.6). Ki67 or TLR5 showed no association with disease progression. In this matched case-control study, p53 expression associated with a high risk of malignant progression in Barrett's low-grade dysplasia. Routine staining of p53 is indicated in expert confirmed low-grade dysplasia., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
17. Risk of progression in Barrett's esophagus based on diagnoses of general and gastrointestinal pathologists. A retrospective case-control study from Northern and Central Finland.
- Author
-
Huhta H, Melkko J, Kuopio T, Karttunen TJ, and Helminen O
- Subjects
- Adenocarcinoma, Case-Control Studies, Disease Progression, Finland, Humans, Hyperplasia, Metaplasia, Pathologists, Retrospective Studies, Barrett Esophagus pathology, Esophageal Neoplasms pathology, Precancerous Conditions pathology
- Abstract
Background: Esophageal adenocarcinoma (EAC) is the sixth leading cause of cancer-related death worldwide. It develops through Barrett's metaplasia - dysplasia sequence. However, the effectiveness of endoscopic surveillance is limited, since diagnosis of low-grade dysplasia (LGD) is known to be challenging for pathologists. Our aim was to compare the risk of Barrett's progression based on diagnoses of general and expert gastrointestinal (GI) pathologists in a population-based cohort., Methods: A total of 60 patients with non-dysplastic metaplasia (BE) or LGD progressing to high grade dysplasia (HGD) or EAC during follow-up could be identified in the population. For comparison, series representing non-progressive BE ( n = 56) and LGD cases ( n = 54), matched for age, gender, and length of follow-up were collected. All available original HE stained slides ( n = 292) were blindly re-evaluated by two experienced GI pathologists and patient groups of progressive non-progressive BE and LGD were formed according to revised diagnoses., Results: Original diagnosis for each sample was changed in 25% of BE, 59% of LGD, and 33% of HGD diagnoses. Of the original LGD diagnoses, 53% were downgraded to BE or indefinite for dysplasia (ID). Of LGD diagnoses made by an expert GI pathologist, 61% were in the progressive LGD group, whereas only 42% of general pathologists' LGD diagnoses were in the progressive LGD group., Conclusion: Based on this retrospective case-control study, LGD is strongly over-diagnosed among general pathologists. LGD diagnosed by expert GI pathologists predicts progressive disease. Recommendation for consensus diagnosis by expert GI pathologists is justified also in the Finnish population-based setting.
- Published
- 2022
- Full Text
- View/download PDF
18. Monocarboxylate Transporters 1 and 4 and Prognosis in Small Bowel Neuroendocrine Tumors.
- Author
-
Hiltunen N, Rintala J, Väyrynen JP, Böhm J, Karttunen TJ, Huhta H, and Helminen O
- Abstract
Monocarboxylate transporters (MCTs) are cell membrane proteins transporting lactate, pyruvate, and ketone bodies across the plasma membrane. The prognostic role of MCTs in neuroendocrine tumors is unknown. We aimed to analyze MCT1 and MCT4 expression in small bowel neuroendocrine tumors (SB-NETs). The cohort included 109 SB-NETs and 61 SB-NET lymph node metastases from two Finnish hospitals. Tumor samples were immunohistochemically stained with MCT1 and MCT4 monoclonal antibodies. The staining intensity, percentage of positive cells, and stromal staining were assessed. MCT1 and MCT4 scores (0, 1 or 2) were composed based on the staining intensity and the percentage of positive cells. Survival analyses were performed with the Kaplan-Meier method and Cox regression, adjusted for confounders. The primary outcome was disease-specific survival (DSS). A high MCT4 intensity in SB-NETs was associated with better DSS when compared to low intensity (85.7 vs. 56.6%, p = 0.020). A high MCT4 percentage of positive cells resulted in better DSS when compared to a low percentage (77.4 vs. 49.1%, p = 0.059). MCT4 scores 0, 1, and 2 showed DSS of 52.8 vs. 58.8 vs. 100% ( p = 0.025), respectively. After adjusting for confounders, the mortality hazard was lowest in the patients with a high MCT4 score. MCT1 showed no association with survival. According to our study, a high MCT4 expression is associated with an improved prognosis in SB-NETs.
- Published
- 2022
- Full Text
- View/download PDF
19. Carbonic Anhydrases II, IX, and XII in Reflux Esophagitis.
- Author
-
Nortunen M, Väkiparta N, Parkkila S, Saarnio J, Huhta H, and Karttunen TJ
- Subjects
- Bicarbonates, Carbonic Anhydrase II metabolism, Humans, Isoenzymes, Carbonic Anhydrases metabolism, Carcinoma, Squamous Cell, Esophagitis, Esophagitis, Peptic, Gastroesophageal Reflux
- Abstract
Background: The pathogenesis of gastroesophageal reflux disease (GERD) has not been resolved in detail. Esophageal epithelial cells provide resistance to acidic reflux via several mechanisms, many of which involve buffering acid with bicarbonate and transporting protons. Carbonic anhydrases (CAs) are enzymes that control the acid-base balance by catalyzing the reversible hydration of carbon dioxide to produce bicarbonate and hydrogen ions., Aims: We aimed to determine the immunohistochemical expression patterns of CAII, CAIX, and CAXII in the normal esophageal squamous epithelium and in patients with GERD., Methods: We evaluated 82 biopsy samples, including 26 with a histologically normal esophagus, 26 with histologically mild esophagitis, and 30 with severe esophagitis. Expression patterns of CAII, CAIX, and CAXII in the esophageal squamous epithelium were determined by immunohistochemical staining., Results: Cytoplasmic CAII expression was predominantly detected in the upper luminal part of the squamous epithelium and was significantly (p < 0.01) increased in GERD. Expression of CAIX was essentially membranous. The isozyme was constantly present in the peripapillary cells. In the interpapillary areas, clustered expression was observed to emerge and increase significantly (p < 0.01) in esophagitis. CAXII expression was the most abundant of the isozymes and was mainly membranous. In the normal squamous epithelium, CAXII expression was confined to the basal layer; in severe esophagitis, CAXII expression increased significantly in both basal (p < 0.05) and superficial (p < 0.01) halves of the epithelium., Conclusions: We demonstrate upregulated expression of CAII, CAIX, and CAXII in GERD. The increase in expression likely contributes to esophageal epithelial resistance to acidic reflux., (© 2021. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
20. Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Helicobacter pylori Infection in Gastroscopy Referral Patients: Clinical Validation of the New-Generation GastroPanel ® Test.
- Author
-
Koivurova OP, Koskela R, Blomster T, Ala-Rämi A, Lumme H, Kettunen O, Hukkanen J, Karttunen TJ, Mäkinen M, Ronkainen J, and Syrjänen K
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Antibodies, Bacterial blood, Biomarkers blood, Biopsy, Enzyme-Linked Immunosorbent Assay, Female, Finland, Gastritis, Atrophic blood, Gastritis, Atrophic microbiology, Helicobacter Infections blood, Helicobacter Infections microbiology, Helicobacter pylori immunology, Host-Pathogen Interactions, Humans, Male, Middle Aged, Predictive Value of Tests, Referral and Consultation, Reproducibility of Results, Young Adult, Gastrins blood, Gastritis, Atrophic diagnosis, Gastroscopy, Helicobacter Infections diagnosis, Helicobacter pylori pathogenicity, Pepsinogen A blood, Pepsinogen C blood, Serologic Tests
- Abstract
Background/aim: Prompted by the increasing demand of non-invasive diagnostic tools for screening of gastric cancer (GC) risk conditions, i.e., atrophic gastritis (AG) and Helicobacter pylori (Hp) infection, the GastroPanel
® test (GP: biomarker panel of PGI, PGII, G-17, Hp IgG ELISA) that was developed in the early 2000's, was recently updated to a new-generation (unified GP) test version. This clinical validation study evaluated the diagnostic accuracy of the new-generation GP test in detection of AG and Hp among gastroscopy referral patients in a University Clinic., Patients and Methods: Altogether, 522 patients were enrolled among the patients referred for gastroscopy at the Gastro Center, Oulu University Hospital (OUH). All patients underwent gastroscopy with biopsies classified using the Updated Sydney System (USS), and blood sampling for GP testing., Results: Biopsy-confirmed AG was found in 10.2% (53/511) of the patients. The overall agreement between the GP and the USS classification was 92.4% (95%CI=90.0-94.6%), with the weighted kappa (κw ) of 0.861 (95%CI=0.834-0.883). In ROC analysis using moderate/severe AG of the corpus (AGC2+) as the endpoint, AUC=0.952 (95%CI=0.891-1.000) and AUC=0.998 (95%CI=0.996-1.000) for PGI and PGI/PGII, respectively. Hp IgG antibody ELISA detected biopsy-confirmed Hp-infection with AUC=0.993 (95%CI=0.987-0.999)., Conclusion: The new generation GastroPanel® is a precise test for non-invasive diagnosis of atrophic gastritis and Hp-infection in dyspeptic patients referred for diagnostic gastroscopy., (Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
21. Carbonic Anhydrases II and IX in Non-ampullary Duodenal Adenomas and Adenocarcinoma.
- Author
-
Nortunen M, Parkkila S, Saarnio J, Huhta H, and Karttunen TJ
- Subjects
- Adenocarcinoma pathology, Adult, Aged, Antigens, Neoplasm genetics, Carbonic Anhydrase II genetics, Carbonic Anhydrase IX genetics, Cell Differentiation, Cohort Studies, Duodenal Neoplasms pathology, Female, Humans, Male, Middle Aged, Adenocarcinoma enzymology, Antigens, Neoplasm metabolism, Carbonic Anhydrase II metabolism, Carbonic Anhydrase IX metabolism, Duodenal Neoplasms enzymology
- Abstract
Non-ampullary duodenal adenocarcinoma (DAC) is a rare malignancy. Little information is available concerning the histopathological prognostic factors associated with DAC. Carbonic anhydrases (CAs) are metalloenzymes catalyzing the universal reaction of CO
2 hydration. Isozymes CAII, CAIX, and CAXII are associated with prognosis in various cancers. Our aim was to analyze the immunohistochemical expressions of CAII, CAIX, and CAXII in normal duodenal epithelium, duodenal adenomas, and adenocarcinoma and their associations with clinicopathological variables and survival. Our retrospective study included all 27 DACs treated in Oulu University Hospital during years 2000-2020. For comparison, samples of 42 non-ampullary adenomas were collected. CAII expression was low in duodenal adenomas and adenocarcinoma. CAIX expression in adenomas and adenocarcinoma was comparable with the high expression of normal duodenal crypts. Expression patterns in carcinomas were largely not related to clinicopathological features. However, low expression of CAII associated with poorer differentiation of the tumor ( p =0.049) and low expression of CAIX showed a trend for association with nodal spread, although statistical significance was not reached ( p =0.091). CAII and CAIX lost their epithelial polarization and staining intensity in adenomas. CAXII expression was not detected in the studied samples. CAs were not associated with survival. The prognostic value of CAII and CAIX downregulation should be further investigated. Both isozymes may serve as biomarkers of epithelial dysplasia in the duodenum.- Published
- 2021
- Full Text
- View/download PDF
22. Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor.
- Author
-
Nortunen M, Väkiparta N, Porvari K, Saarnio J, Karttunen TJ, and Huhta H
- Subjects
- Adult, Aged, Aged, 80 and over, Biomarkers analysis, Case-Control Studies, Esophageal Mucosa immunology, Esophagitis, Peptic genetics, Esophagitis, Peptic immunology, Female, Humans, Immunity, Innate, Immunohistochemistry, In Situ Hybridization, Male, Middle Aged, Receptors, Cytoplasmic and Nuclear genetics, Severity of Illness Index, Toll-Like Receptor 2 genetics, Toll-Like Receptor 4 genetics, Young Adult, Esophageal Mucosa chemistry, Esophagitis, Peptic metabolism, Receptors, Cytoplasmic and Nuclear analysis, Toll-Like Receptor 2 analysis, Toll-Like Receptor 4 analysis
- Abstract
The pathogenesis of gastroesophageal reflux disease (GERD) is not fully understood. It involves the activation of mucosal immune-mediated and inflammatory responses. Toll-like receptors (TLR) 2 and TLR4 are pattern-recognition receptors of the innate immune system; they recognize microbial and endogenous ligands. Farnesoid X receptor (FXR) is a bile acid receptor that regulates the inflammatory response. We aimed to evaluate TLR2, TLR4 and FXR expression patterns in GERD. We re-evaluated 84 oesophageal biopsy samples according to the global severity (GS) score, including 26 cases with histologically normal oesophagus, 28 with histologically mild oesophagitis and 30 with severe oesophagitis. We used immunohistochemistry and in situ hybridization to assess the expression patterns of TLR2, TLR4 and FXR in oesophageal squamous cells. Immunohistochemistry showed that nuclear and cytoplasmic TLR2 was expressed predominantly in the basal layer of normal oesophageal epithelium. In oesophagitis, TLR2 expression increased throughout the epithelium, and the superficial expression was significantly more intensive compared to normal epithelium, p <0.01. Nuclear and cytoplasmic TLR4 was expressed throughout the thickness of squamous epithelium, with no change in oesophagitis. FXR was expressed in the nuclei of squamous cells, and the intensity of the expression increased significantly in oesophagitis (p <0.05). FXR expression correlated with basal TLR2. In situ hybridization confirmed the immunohistochemical expression patterns of TLR2 and TLR4. In GERD, TLR2, but not TLR4, expression was upregulated which indicates that innate immunity is activated according to a specific pattern in GERD. FXR expression was increased in GERD and might have a regulatory connection to TLR2., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
23. Differential synovial tissue expression of TLRs in seropositive and seronegative rheumatoid arthritis: A preliminary report.
- Author
-
Abdelwahab A, Palosaari S, Abdelwahab SA, Rifaai RA, El-Tahawy NF, Saber EA, Nousiainen T, Valkealahti M, Huhtakangas J, Karttunen TJ, and Lehenkari P
- Subjects
- Arthritis, Rheumatoid pathology, Biomarkers, Humans, Immunohistochemistry, Osteoarthritis diagnosis, Osteoarthritis etiology, Osteoarthritis metabolism, Serologic Tests, Synovial Membrane pathology, Toll-Like Receptors genetics, Arthritis, Rheumatoid etiology, Arthritis, Rheumatoid metabolism, Gene Expression, Synovial Membrane metabolism, Toll-Like Receptors metabolism
- Abstract
Toll-like receptors (TLRs) are known to have an important role in triggering the innate immune response and in priming antigen-specific adaptive immunity and inflammation. The differences in synovial tissue expression of the TLRs between seronegative and seropositive rheumatoid arthritis (RA) were examined from 9 seropositive RA, 5 seronegative RA and 4 osteoarthritis (OA) patients. Synovitis status was assessed using Krenn's scoring and TLR 1-9 expression by immunohistochemistry. Tissue citrulline content was analysed by HPLC method. In RA TLR expression was generally higher than in OA. TLR2 expression was higher in both seronegative and seropositive RA compared to OA. TLR 1, 4 and 8 expressions were higher in seropositive RA than in seronegative RA or in OA. For TLRs 3, 5, 6, 7 and 9 local differences of expression were found between groups. TLR 1-9 expression correlated with the synovitis grade. No statistical difference was found in synovial tissue citrulline content between the groups. In seropositive RA, the TLR repertoire in the synovial tissue differs from seronegative RA and could explain differences in disease outcomes. The high expression of protein sensing (TLR1, TLR2 and TLR4) and nucleic acid sensing TLRs (TLR7, TLR8 and TLR9) in the seropositive RA could make the synovium primed for reacting to citrullinated proteins and nucleic acids that could be released to extracellular space in formation of neutrophil extracellular traps. This reactivity could be augmented by Fc receptor activation by anti-citrullinated protein antibody immunocomplexes associated with seropositive RA.
- Published
- 2021
- Full Text
- View/download PDF
24. Immune Cell Infiltrate and Prognosis in Gastric Cancer.
- Author
-
Kemi N, Hiltunen N, Väyrynen JP, Pohjanen VM, Helminen O, Junttila A, Mrena J, Böhm J, Huhta H, Leppänen J, Karttunen TJ, and Kauppila JH
- Abstract
Purpose: To examine and compare the prognostic value of immune cell score (ICS) and Klintrup-Mäkinen (KM) grade in gastric cancer., Methods: Gastric adenocarcinoma tissues from samples of 741 patients surgically treated in two hospitals in Finland were assessed for ICS and KM grade. Cox regression with adjustment for confounders provided hazard ratios (HRs) and 95% CIs. Subgroup analyses were performed in intestinal and diffuse type subgroups. The primary outcome was 5-year overall survival., Results: High ICS was associated to longer 5-year survival (adjusted HR 0.70, 95% CI 0.52-0.94), compared to low ICS. The difference was significant in intestinal type subgroup (adjusted HR 0.54, 95% CI 0.36-0.81) but not in diffuse type subgroup (adjusted HR 0.92, 95% CI 0.58-1.46). High KM grade was an independent prognostic factor for longer 5-year overall survival (adjusted HR 0.59, 95% CI 0.45-0.77) in both intestinal (adjusted HR 0.61, 95% CI 0.44-0.85) and diffuse subgroups (adjusted HR 0.52, 95% CI 0.31-0.86). ICS and KM grade were moderately correlated (ρ = 0.425). When both immune cell score and KM grade were included in the regression analysis, only KM grade remained prognostic., Conclusions: Both ICS and KM grade are prognostic factors in gastric adenocarcinoma, but immunohistochemistry-based ICS might not have additional prognostic value over hematoxylin-eosin-based KM grade.
- Published
- 2020
- Full Text
- View/download PDF
25. Cohort profile: gastric cancer in the population-based, Finnish National Esophago-Gastric Cancer Cohort (FINEGO) Study.
- Author
-
Kauppila JH, Ohtonen P, Rantanen T, Tyrväinen T, Toikkanen V, Pääaho M, Valtola A, Räsänen J, Kallio R, Sihvo E, Saarnio J, Karttunen TJ, Pohjanen VM, Ristimäki A, Laine S, and Kokkola A
- Subjects
- Aged, Cohort Studies, Female, Finland epidemiology, Gastrectomy, Humans, Male, Neoplasm Staging, Adenocarcinoma epidemiology, Adenocarcinoma pathology, Adenocarcinoma surgery, Stomach Neoplasms epidemiology, Stomach Neoplasms pathology, Stomach Neoplasms surgery
- Abstract
Purpose: The Finnish National Esophago-Gastric Cancer Cohort (FINEGO) was established with the aim of identifying factors that could contribute to improved outcomes in oesophago-gastric cancer. The aim of this study is to describe the patients with gastric cancer included in FINEGO., Participants: A total of 10 457 patients with gastric cancer or tumour diagnosis in the Finnish Cancer Registry or the Finnish Patient Registry during 1987-2016 were included in the cohort, with follow-up from Causes of Death Registry until 31 December 2016. All of the participants were at least 18 years of age, and had undergone either resectional or endoscopic mucosal surgery with curative or palliative intent., Findings to Date: Of the 10 457 patients, 90.1% were identified to have cancer in both cancer and patient registries. In all, the median age was 70 at the time of surgery, 54.5% of the patients were men and 64.4% had no comorbidities. Education data were available for 31.1% of the patients, of whom the majority had had <12 years of formal education. Of the 7798 with cancer staging data available, 41.1% had a local cancer. Adenocarcinoma was the most common (94.2%) histological type. Almost all patients underwent open gastrectomy and 214% in hospitals with annual volume of more than 30 gastrectomies per year. A total of 8561 deaths occurred during the study period, of which 6474 were due to oesophago-gastric cancers. The 5-year survival was 34.6% and 5-year cancer-specific survival was 39.7%., Future Plans: The data in FINEGO can be currently used for registry-based research but is being expanded by data extraction from patient records and scanning of histological samples from the Finnish biobanks. Initially, we are planning on studies on the national trends in treatment and mortality, and studies on the demographic factors and their influence on survival., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2020
- Full Text
- View/download PDF
26. Cohort profile: a nationwide population-based retrospective assessment of oesophageal cancer in the Finnish National Esophago-Gastric Cancer Cohort (FINEGO).
- Author
-
Söderström HK, Räsänen J, Saarnio J, Toikkanen V, Tyrväinen T, Rantanen T, Valtola A, Ohtonen P, Pääaho M, Kokkola A, Kallio R, Karttunen TJ, Pohjanen VM, Ristimäki A, Laine S, Sihvo E, and Kauppila JH
- Subjects
- Adolescent, Adult, Esophagectomy, Finland epidemiology, Humans, Male, Retrospective Studies, Esophageal Neoplasms epidemiology, Esophageal Neoplasms surgery, Stomach Neoplasms epidemiology, Stomach Neoplasms surgery
- Abstract
Purpose: The Finnish National Esophago-Gastric Cancer Cohort (FINEGO) was established to combine the available registry data with detailed patient information to form a comprehensive, retrospective, population-based research platform of surgically treated oesophageal and gastric cancer in Finland. This cohort profile describes the 2045 surgically treated patients with oesophageal cancer included in the FINEGO cohort., Participants: Registry data were collected from the National Cancer, Patient, Education and Death Registries from 1 January 1987 to 31 December 2016. All patients over 18 years of age, who had either curative surgery, palliative surgery or salvage surgery for primary cancer in the oesophagus are included in this study., Findings to Date: 2045 patients had surgery for oesophageal cancer in the selected time period. 67.2% were man, and the majority had only minor comorbidities. The proportions of adenocarcinomas and squamous cell carcinomas were 43.1% and 44.4%, respectively, and 12.5% had other or missing histology. Only about 23% of patients received neoadjuvant therapy. Oesophagectomy was the treatment of choice and most patients were treated at low-volume centres, but median annual hospital volume increased over time. Median overall survival was 23 months, 5-year survival for all patients in the cohort was 32.9% and cancer-specific survival was 36.5%., Future Plans: Even though Finland only has a population of 5.5 million, surgery for oesophageal carcinoma has not been centralised and therefore previously reported results have mostly been small, single-centre cohorts. Because of FINEGO, we now have a population-based, unselected cohort of surgically treated patients, enabling research on national trends over time regarding oesophageal cancer, including patient characteristics, tumour histology, stage and neoadjuvant treatment, surgical techniques, hospital volumes and patient mortality. Data collection is ongoing, and the cohort will be expanded to include more detailed data from patient records and national biobanks., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2020
- Full Text
- View/download PDF
27. Systemic inflammation is associated with circulating cell death released keratin 18 fragments in colorectal cancer.
- Author
-
Sirniö P, Väyrynen JP, Mutt SJ, Herzig KH, Walkowiak J, Klintrup K, Mäkelä J, Karttunen TJ, Mäkinen MJ, and Tuomisto A
- Subjects
- Cell Death, Female, Humans, Inflammation, Male, Prognosis, Colorectal Neoplasms, Keratin-18
- Abstract
Systemic inflammation is a stage-independent marker of poor prognosis in colorectal cancer (CRC), activated in a complex, multifactorial process. It has been proposed that one of the main factors driving systemic inflammation may be tumor necrosis. Keratin 18 (KRT18) fragments are released from dead cells and their serum levels are markers for apoptotic and necrotic cell death. In CRC, high KRT18 levels associate with advanced disease, but their relationship with tumor necrosis and systemic inflammation is unknown. In this study, serum total soluble KRT18 (tKRT18) and apoptosis-related, caspase-cleaved fragment (aKRT18) levels were measured preoperatively from 328 CRC patients, and their difference was calculated to assess necrosis related KRT18 (nKRT18) levels. The relationships of these markers with tumor necrosis, clinicopathologic features, systemic inflammation markers (C-reactive protein, albumin, and 13 cytokines), and survival were analyzed. High serum tKRT18, aKRT18, and nKRT18 levels showed association with a higher extent of tumor necrosis, distant metastasis, and increased levels of several markers of systemic inflammation, including CXCL8. High serum tKRT18 (multivariable HR 1.94, 95% CI 1.28-2.95, p = .002) and nKRT18 (multivariable HR 1.87, 95% CI 1.24-2.82, p = .003) levels were associated with poor overall survival independent of potential confounding factors. Our results show that tumor necrosis in CRC contributes to serum levels of KRT18 fragments, and both necrosis and KRT18 levels associate with systemic inflammation. Moreover, we show that serum tKRT18 and nKRT18 levels have independent prognostic value in CRC. Our observations confirm the link between cell death and systemic inflammation., (© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.)
- Published
- 2020
- Full Text
- View/download PDF
28. Putative anoikis-resistant subpopulations in colorectal carcinoma: a marker of adverse prognosis.
- Author
-
Patankar M, Mattila T, Väyrynen JP, Klintrup K, Mäkelä J, Tuomisto A, Nieminen P, Mäkinen MJ, and Karttunen TJ
- Subjects
- Adenocarcinoma metabolism, Aged, Colorectal Neoplasms metabolism, Extracellular Matrix Proteins metabolism, Female, Finland, Humans, Immunohistochemistry, Male, Middle Aged, Prognosis, Prospective Studies, Survival Analysis, Adenocarcinoma pathology, Anoikis, Biomarkers, Tumor metabolism, Colorectal Neoplasms pathology
- Abstract
Anoikis is a form of apoptosis induced when a cell loses contact with the extracellular matrix (ECM). Anoikis resistance is essential for metastasis formation, yet only detectable by in vitro experiments. We present a method for quantitation of putative anoikis-resistant (AR) subpopulations in colorectal carcinoma (CRC) and evaluate their prognostic significance. We studied 137 CRC cases and identified cell subpopulations with and without stromal or extracellular matrix (ECM) contact with hematoxylin-and-eosin-stained sections and immunohistochemistry for laminin and type IV collagen. Suprabasal cells of micropapillary structures and inner cells of cribriform and solid structures lacked both stromal contact and contact with ECM proteins. Apoptosis rate (M30) was lower in these subpopulations than in the other carcinoma cells, consistent with putative AR subpopulation. We determined the areal density of these subpopulations (number/mm
2 tumor tissue), and their high areal density independently indicates low cancer-specific survival. In conclusion, we show evidence that subpopulations of carcinoma cells in micropapillary, cribriform, and solid structures are resistant to anoikis as shown by lack of ECM contact and low apoptosis rate. Abundance of these subpopulations is a new independent indicator of poor prognosis in CRC, consistent with the importance of anoikis resistance in the formation of metastasis., (© 2020 The Authors. APMIS published by John Wiley & Sons Ltd on behalf of Scandinavian Societies for Medical Microbiology and Pathology.)- Published
- 2020
- Full Text
- View/download PDF
29. Histological assessment of stromal maturity as a prognostic factor in surgically treated gastric adenocarcinoma.
- Author
-
Kemi NA, Eskuri M, Pohjanen VM, Karttunen TJ, and Kauppila JH
- Subjects
- Adenocarcinoma pathology, Adenocarcinoma surgery, Cohort Studies, Feasibility Studies, Female, Finland, Humans, Kaplan-Meier Estimate, Male, Prognosis, Proportional Hazards Models, Reproducibility of Results, Retrospective Studies, Stomach pathology, Stomach Neoplasms pathology, Stomach Neoplasms surgery, Stromal Cells pathology, Adenocarcinoma diagnosis, Stomach Neoplasms diagnosis
- Abstract
Aims: Histological assessment of stromal maturity is a potential prognostic factor in colorectal cancer, but its applicability in gastric adenocarcinoma is completely unknown. The aim of this study was to evaluate the feasibility and prognostic significance of assessing stromal maturity in gastric adenocarcinoma., Methods and Results: This study was conducted retrospectively in a cohort of 583 gastric adenocarcinoma patients treated surgically in Oulu University Hospital, Finland between 1983 and 2016. The original diagnostic slides were used for assessment of stromal maturity. Patients were divided into mature stroma and immature stroma groups, and stromal maturity was analysed in relation to 5-year and overall survival (OS). The primary outcome of the study was 5-year survival, and the secondary outcome was OS. The kappa-coefficient for interobserver agreement was 0.609. Patients with immature stroma had worse 5-year survival compared to patients with mature stroma [adjusted hazard ratio (HR) = 1.32, 95% confidence interval (CI) = 1.06-1.64]. Stromal maturity was significantly associated with 5-year survival in intestinal-type subgroup (adjusted HR = 0.63, 95% CI = 1.20-2.21), but not in the diffuse-type subgroup (adjusted HR = 1.21, 95% CI = 0.87-1.70)., Conclusions: Stromal maturity is an independent prognostic factor in gastric adenocarcinoma, and it can be analysed with moderate reproducibility., (© 2019 John Wiley & Sons Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
30. KRAS and BRAF mutations induce anoikis resistance and characteristic 3D phenotypes in Caco‑2 cells.
- Author
-
Patankar M, Eskelinen S, Tuomisto A, Mäkinen MJ, and Karttunen TJ
- Subjects
- Biomarkers, Tumor, Caco-2 Cells, Cell Line, Tumor, Colorectal Neoplasms genetics, Colorectal Neoplasms metabolism, Gene Expression Regulation, Neoplastic, Humans, Anoikis genetics, Mutation, Phenotype, Proto-Oncogene Proteins B-raf genetics, Proto-Oncogene Proteins p21(ras) genetics
- Abstract
In a number of types of cancer, anoikis, a form of apoptosis induced by loss of extracellular matrix (ECM) attachment, is disturbed. Anoikis resistance is essential in the formation of metastases. A recent study identified carcinoma cell subpopulations surviving without ECM contact in pathological specimens of colorectal cancer. The occurrence of these subpopulations indicated anoikis resistance. In the present study, it is demonstrated that KRAS and BRAF mutations induce anoikis resistance in colon cancer (Caco‑2) cells. In 3D cultures, Caco‑2 cells transfected with mutated KRAS or BRAF formed multicellular structures analogous to anoikis‑resistant subpopulations in actual carcinomas, and serve as an in vitro model for anoikis resistance. Caco‑2 cell lines were constructed, with KRAS or BRAF mutations, using retroviral delivery. The current study investigated anoikis resistance using an Annexin V apoptosis test from suspension cultures. 3D in vitro cultures, which were generated in collagen‑matrigel mixtures, were assessed using confocal microscopy. 3D cultures embedded in paraffin were analyzed using conventional histopathology. In suspension cultures, Caco‑2 cells with KRAS or BRAF mutations indicated a significantly lower proportion of Annexin positivity than the native Caco‑2 cells, indicating that these mutations induce anoikis resistance in Caco‑2 cells. 3D cultures displayed native Caco‑2 cells forming polarized cysts with a single layer thick epithelium, whereas Caco‑2 cells with KRAS or BRAF mutations formed partially filled cystic structures or solid round structures where only the outermost layer was in contact with the ECM. Additionally, KRAS mutations induced reversed polarity to Caco‑2 cells along with the emergence of solid growth. The present study demonstrated that KRAS and BRAF mutations induce anoikis resistance in Caco‑2 colorectal cancer cells. The growth patterns generated from the KRAS and BRAF mutated cells in 3D cultures revealed a resemblance to the putative anoikis‑resistant subpopulations in actual carcinomas, including micropapillary structures and solid tumor cell islands. Additionally, KRAS mutation induced the emergence of inverted polarity. In conclusion, 3D cultures with modified Caco‑2 cells serve as a valid in vitro model for anoikis resistance and inverted polarity.
- Published
- 2019
- Full Text
- View/download PDF
31. Serum TLR2 and TLR4 levels in colorectal cancer and their association with systemic inflammatory markers, tumor characteristics, and disease outcome.
- Author
-
Paarnio K, Tuomisto A, Väyrynen SA, Väyrynen JP, Klintrup K, Ohtonen P, Mäkinen MJ, Mäkelä J, and Karttunen TJ
- Subjects
- Adult, Aged, Aged, 80 and over, Biomarkers, Tumor blood, Carcinoma pathology, Case-Control Studies, Colorectal Neoplasms pathology, Enzyme-Linked Immunosorbent Assay, Female, Glasgow Outcome Scale, Humans, Immunohistochemistry, Male, Middle Aged, Prognosis, ROC Curve, Survival Analysis, Carcinoma blood, Colorectal Neoplasms blood, Intestinal Mucosa pathology, Toll-Like Receptor 2 blood, Toll-Like Receptor 4 blood
- Abstract
Toll-like receptors (TLRs) are involved in colorectal cancer (CRC) pathogenesis. However, the significance of serum TLR concentrations in CRC is unknown. We analyzed serum TLR2 and TLR4 concentrations with ELISA in preoperative samples from 118 patients with CRC and 88 matched controls. We also assessed tissue TLR expression with immunohistochemistry and by detecting serum determinants of systemic inflammation. Most participants (>70%) had undetectable serum TLR2. The mean serum TLR4 levels were lower in patients than in controls (1.1 vs 1.8 ng/mL; p = 0.015). Undetectable TLR4 was more common in stage I (39%) than in stages II-IV (11%, p < 0.001). TLR2 or TLR4 expression in tumor cells did not correlate with serum levels, but abundant TLR2 expression in normal colon epithelium was associated with detectable serum TLR2 (p = 0.034). Undetectable serum TLR2 was linked to high modified Glasgow prognostic scores (p = 0.010), high CRP levels (p = 0.013), blood vessel invasion (p = 0.013), and tended to be associated with worse 5-year survival (p = 0.052). In conclusion, serum TLR2 levels were inversely associated with systemic inflammation in patients with CRC. Moreover, serum TLR2 levels might depend more on normal colorectal mucosa contributions than on tumor tissue contributions. Further studies are required to assess the prognostic value of serum TLR2., (© 2019 APMIS. Published by John Wiley & Sons Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
32. Platelet count, aspirin use, and characteristics of host inflammatory responses in colorectal cancer.
- Author
-
Väyrynen JP, Väyrynen SA, Sirniö P, Minkkinen I, Klintrup K, Karhu T, Mäkelä J, Herzig KH, Karttunen TJ, Tuomisto A, and Mäkinen MJ
- Subjects
- Adult, Aged, Biomarkers blood, Cohort Studies, Cytokines blood, Female, Humans, Inflammation drug therapy, Inflammation epidemiology, Inflammation pathology, Inflammation Mediators blood, Male, Middle Aged, Platelet Count, Survival Analysis, Adenocarcinoma blood, Adenocarcinoma mortality, Adenocarcinoma pathology, Adenocarcinoma therapy, Aspirin therapeutic use, Blood Platelets pathology, Colorectal Neoplasms blood, Colorectal Neoplasms mortality, Colorectal Neoplasms pathology, Colorectal Neoplasms therapy, Inflammation blood
- Abstract
Background: Platelets not only contribute to hemostasis but also to the regulation of inflammatory reactions and cancer pathogenesis. We hypothesized that blood platelet count would be associated with systemic inflammation, the densities of tumor infiltrating immune cells, and survival in colorectal cancer (CRC), and these relationships could be altered by aspirin use., Methods: We measured blood platelet count in a cohort of 356 CRC patients and analyzed its relationships with tumor and patient characteristics including aspirin use, markers of systemic inflammation (modified Glasgow Prognostic Score, mGPS; serum levels of CRP, albumin, and 13 cytokines), blood hemoglobin levels, five types of tumor infiltrating immune cells (CD3, CD8, FoxP3, Neutrophil elastase, mast cell tryptase), and survival., Results: Platelet count inversely correlated with blood hemoglobin levels (p < 0.001) and positively correlated with serum levels of CRP and multiple cytokines including IL-1RA, IL-4, IL-6, IL-7, IL-8, IL-12, IFNγ, and PDGF-BB (p < 0.001 for all), while aspirin use was not associated with the levels of systemic inflammatory markers. High platelet count was also associated with high mGPS (p < 0.001) but did not show statistically significant multivariable adjusted associations with the densities of tumor infiltrating immune cells. Higher platelet counts were observed in higher tumor stage (p < 0.001), but platelet count or aspirin use were not associated with patient survival., Conclusions: High platelet count is associated with systemic inflammation in CRC. This study could not demonstrate statistically significant associations between platelet count, aspirin use, and the densities of tumor infiltrating immune cells.
- Published
- 2019
- Full Text
- View/download PDF
33. Tumor Budding and Prognosis in Gastric Adenocarcinoma.
- Author
-
Kemi N, Eskuri M, Ikäläinen J, Karttunen TJ, and Kauppila JH
- Subjects
- Adenocarcinoma mortality, Adult, Aged, Aged, 80 and over, Cohort Studies, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Prognosis, Retrospective Studies, Stomach Neoplasms mortality, Adenocarcinoma pathology, Stomach Neoplasms pathology
- Abstract
Tumor budding has been associated with poor prognosis in several cancer types, but its significance in gastric cancer is unknown. The aim of this study was to assess the prognostic significance of tumor budding in gastric adenocarcinoma, and its main histologic types. Some 583 gastric adenocarcinoma patients who underwent surgery in Oulu University Hospital during the years 1983-2016 were included in this retrospective cohort study. Tumor budding was counted per 0.785 mm fields from the slides originally used for diagnostic purposes. Patients were divided into low-budding (<10 buds) and high-budding (≥10 buds) groups. Tumor budding was analyzed in relation to 5-year survival and overall survival. Cox regression was used to calculate hazard ratios (HR) with 95% confidence intervals (CI), adjusted for confounders. Determining tumor budding was difficult in diffuse-type cancer due to the uncohesive growth pattern of these tumors. Patients with high tumor budding had worse 5-year survival compared with patients with low tumor budding (adjusted HR, 1.55; 95% CI, 1.20-2.01). In intestinal-type adenocarcinomas, the high-budding group had significantly poorer 5-year survival compared with the low-budding group (adjusted HR, 1.57; 95% CI, 1.14-2.15). There were no differences in 5-year survival between the budding groups in the diffuse type adenocarcinoma. In conclusion, high tumor budding is an independent prognostic factor in gastric adenocarcinoma, but its value is limited to the intestinal type of gastric adenocarcinoma. In diffuse type gastric adenocarcinoma, the assessment of tumor budding is hardly feasible, and it does not have prognostic relevance.
- Published
- 2019
- Full Text
- View/download PDF
34. Finnish National Esophago-Gastric Cancer Cohort (FINEGO) for studying outcomes after oesophageal and gastric cancer surgery: a protocol for a retrospective, population-based, nationwide cohort study in Finland.
- Author
-
Kauppila JH, Ohtonen P, Karttunen TJ, Kokkola A, Laine S, Rantanen T, Ristimäki A, Räsänen JV, Saarnio J, Sihvo E, Toikkanen V, and Tyrväinen T
- Subjects
- Carcinoma pathology, Cohort Studies, Esophageal Neoplasms pathology, Esophagogastric Junction pathology, Esophagogastric Junction surgery, Finland, Humans, Postoperative Complications epidemiology, Prognosis, Reoperation, Retrospective Studies, Sick Leave statistics & numerical data, Stomach Neoplasms pathology, Treatment Outcome, Carcinoma surgery, Esophageal Neoplasms surgery, Mortality, Stomach Neoplasms surgery
- Abstract
Introduction: Surgery for oesophageal and gastric cancers is associated with high morbidity, mortality and poor quality of life postoperatively. The Finnish National Esophago-Gastric Cancer Cohort has been established with the aim of identifying factors that could contribute to improved outcomes in oesophago-gastric cancer., Methods and Analysis: All patients with oesophageal and gastric cancer diagnosed in Finland between 1987 and 2015 will be identified from the Finnish national registries. The Finnish Cancer Registry and Finnish Patient Registry will be used to identify patients that fulfil the inclusion criteria for the study: (1) diagnosis of oesophageal, gastro-oesophageal junction, or gastric cancer, (2) any surgical treatment for the diagnosed cancer and (3) age of 18 or over at the time of diagnosis. Clinical variables and complication information will be retrieved in extensive data collection from the medical records of the relevant Finnish hospitals and complete follow-up for vital status from Statistics Finland. Primary endpoint is overall all-cause mortality and secondary endpoints include complications, reoperations, medication use and sick leaves. Sub-studies will be implemented within the cohort to investigate specific populations undergoing oesophageal and gastric cancer surgery. The initial estimated sample size is 1800 patients with surgically treated oesophageal cancer and 7500 patients with surgically treated gastric cancer., Ethics and Dissemination: The study has been approved by the Ethical Committee in Northern Ostrobothnia, Finland and The National Institute for Health and Welfare, Finland. Study findings will be disseminated via presentations at conferences and publications in peer-reviewed journals., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2019
- Full Text
- View/download PDF
35. Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival.
- Author
-
Sirniö P, Väyrynen JP, Klintrup K, Mäkelä J, Karhu T, Herzig KH, Minkkinen I, Mäkinen MJ, Karttunen TJ, and Tuomisto A
- Subjects
- Aged, Amino Acids classification, Colorectal Neoplasms complications, Colorectal Neoplasms pathology, Disease Progression, Disease-Free Survival, Female, Humans, Inflammation complications, Inflammation pathology, Lymphocytes pathology, Male, Middle Aged, Neoplasm Staging, Neutrophils pathology, Prognosis, Amino Acids blood, Biomarkers, Tumor blood, Colorectal Neoplasms blood, Cytokines blood, Inflammation blood
- Abstract
Background: Cancer cachexia is a complex wasting syndrome affecting patients with advanced cancer, with systemic inflammation as a key component in pathogenesis. Protein degradation and release of amino acids (AAs) in skeletal muscle are stimulated in cachexia. Here, we define factors contributing to serum AA levels in colorectal cancer (CRC)., Methods: Serum levels of nine AAs were characterised in 336 CRC patients and their relationships with 20 markers of systemic inflammatory reaction, clinicopathological features of cancers and patient survival were analysed., Results: Low serum glutamine and histidine levels and high phenylalanine levels associated with indicators of systemic inflammation, including high modified Glasgow Prognostic Score, high blood neutrophil/lymphocyte ratio and high serum levels of CRP, IL-6 and IL-8. Low levels of serum glutamine, histidine, alanine and high glycine levels also associated with advanced cancer stage and with poor cancer-specific survival in univariate analysis., Conclusions: In CRC, serum AA levels are associated with systemic inflammation and disease stage. These findings may reflect muscle catabolism induced by systemic inflammation in CRC.
- Published
- 2019
- Full Text
- View/download PDF
36. Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma.
- Author
-
Leppänen J, Lindholm V, Isohookana J, Haapasaari KM, Karihtala P, Lehenkari PP, Saarnio J, Kauppila JH, Karttunen TJ, Helminen O, and Huhta H
- Subjects
- Aged, Carcinoma, Pancreatic Ductal pathology, Female, Humans, Immunohistochemistry, Kaplan-Meier Estimate, Male, Middle Aged, Pancreas pathology, Pancreatic Neoplasms pathology, Prognosis, Biomarkers, Tumor biosynthesis, Carcinoma, Pancreatic Ductal metabolism, Fibronectins biosynthesis, Pancreas metabolism, Pancreatic Neoplasms metabolism, Tenascin biosynthesis
- Abstract
Objectives: Pancreatic ductal adenocarcinoma (PDAC) is characterized by abundant stroma with increased expression of tenascin C and fibronectin. Their role and tumor-stroma ratio in PDAC are not well known. The aim of this study was to evaluate tenascin C and fibronectin expression and tumor-stroma ratio and their prognostic relevance in PDAC., Methods: Ninety-five resected PDACs were immunohistochemically stained for tenascin C and fibronectin, and the expression was separately assessed in tumor bulk and front. Tumor-stroma ratio was determined with sections stained with hematoxylin-eosin., Results: Tenascin C and fibronectin were abundantly expressed in the stroma of PDAC, but absent in adjacent normal pancreatic tissue. Fibronectin expression of the bulk was associated with high T class (P = 0.045). In the main analysis, tenascin C and fibronectin expression and tumor-stroma ratio were not associated with patient survival. In a subgroup analysis of early-stage PDAC (T1-T2 tumors), high tenascin C expression in the tumor bulk was associated with poor prognosis (hazard ratio, 8.23; 95% confidence interval, 2.71-24.96)., Conclusions: Tenascin C and fibronectin are abundantly expressed in PDAC, but they seem to have no major association with patient survival. However, in early-stage PDAC, tenascin C expression of the tumor bulk may have prognostic impact. Tumor-stroma ratio has no prognostic value in PDAC.
- Published
- 2019
- Full Text
- View/download PDF
37. Toll-like receptors 2, 4 and 9 and hypoxia markers HIF-1alpha and CAIX in pancreatic intraepithelial neoplasia.
- Author
-
Leppänen J, Helminen O, Huhta H, Kauppila JH, Isohookana J, Haapasaari KM, Karihtala P, Parkkila S, Saarnio J, Lehenkari PP, and Karttunen TJ
- Subjects
- Adult, Aged, Antigens, Neoplasm genetics, Antigens, Neoplasm immunology, Biomarkers, Tumor immunology, Carbonic Anhydrase IX genetics, Carbonic Anhydrase IX immunology, Carcinogenesis genetics, Carcinogenesis immunology, Carcinogenesis pathology, Carcinoma, Pancreatic Ductal immunology, Carcinoma, Pancreatic Ductal pathology, Carcinoma, Pancreatic Ductal surgery, Female, Gene Expression Regulation, Neoplastic, Humans, Hypoxia genetics, Hypoxia immunology, Hypoxia pathology, Hypoxia surgery, Hypoxia-Inducible Factor 1, alpha Subunit genetics, Hypoxia-Inducible Factor 1, alpha Subunit immunology, Immunity, Innate, Immunohistochemistry, Inflammation, Male, Middle Aged, Neoplasms immunology, Neoplasms pathology, Neoplasms surgery, Pancreas immunology, Pancreas pathology, Pancreas surgery, Pancreatic Neoplasms immunology, Pancreatic Neoplasms pathology, Pancreatic Neoplasms surgery, Retrospective Studies, Toll-Like Receptor 2 immunology, Toll-Like Receptor 4 immunology, Toll-Like Receptor 9 immunology, Tumor Microenvironment, Biomarkers, Tumor genetics, Carcinoma, Pancreatic Ductal genetics, Neoplasms genetics, Pancreatic Neoplasms genetics, Toll-Like Receptor 2 genetics, Toll-Like Receptor 4 genetics, Toll-Like Receptor 9 genetics
- Abstract
Pancreatic cancer arises from precursor lesions called pancreatic intraepithelial neoplasia (PanIN) characterized by inflammatory microenvironment. In pancreatic cancer, strong innate immunity and hypoxia responses are typical. Occurrence and relationship of these responses in human PanINs is unknown. We have studied the expression of toll-like receptors (TLR) TLR2, TLR4 and TLR9, and hypoxia markers HIF-1alpha and Carbonic anhydrase IX (CAIX) in normal and inflamed pancreatic ducts, in PanINs and in cancers. The samples of 69 surgically resected pancreatic ductal adenocarcinoma patients were stained using immunohistochemistry. We found TLR2, TLR9, HIF-1alpha and CAIX to be prominently expressed in pancreatic intraepithelial neoplasia. Expression of TLR2 showed a linear increase from PanIN1 to PanIN3, while the highest TLR4 expression was detected in inflamed ducts, and TLR9 expression in PanIN1 lesions. Within the PanIN1-group, nuclear HIF-1alpha correlated with membranous and cytoplasmic TLR2 expression (ρ = 0.982 and 0.815; p < 0.001 and p = 0.025, respectively), and in the PanIN2-group nuclear HIF-1alpha correlated with nuclear TLR9 expression 0.636, p = 0.026). Our findings show that the expression of TLRs 2, 4 and 9, and hypoxia markers HIF-1alpha and CAIX is abnormal in pancreatic intraepithelial neoplasia suggesting that both the innate immunity activation and hypoxia response are involved in early pancreatic carcinogenesis. However, these processes might be independent., (© 2018 APMIS. Published by John Wiley & Sons Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
38. Carbonic anhydrases II, IX, and XII in Barrett's esophagus and adenocarcinoma.
- Author
-
Nortunen M, Huhta H, Helminen O, Parkkila S, Kauppila JH, Karttunen TJ, and Saarnio J
- Subjects
- Adenocarcinoma diagnosis, Adenocarcinoma mortality, Adenocarcinoma pathology, Adult, Aged, Aged, 80 and over, Barrett Esophagus diagnosis, Barrett Esophagus pathology, Biomarkers metabolism, Down-Regulation, Esophageal Neoplasms diagnosis, Esophageal Neoplasms mortality, Esophageal Neoplasms pathology, Female, Follow-Up Studies, Humans, Immunohistochemistry, Male, Middle Aged, Precancerous Conditions diagnosis, Precancerous Conditions pathology, Prognosis, Retrospective Studies, Adenocarcinoma metabolism, Antigens, Neoplasm metabolism, Barrett Esophagus metabolism, Carbonic Anhydrase II metabolism, Carbonic Anhydrase IX metabolism, Carbonic Anhydrases metabolism, Esophageal Neoplasms metabolism, Precancerous Conditions metabolism
- Abstract
The aim of our retrospective study was to investigate the expression and clinical significance of the cancer-associated carbonic anhydrases (CAs) II, IX, and XII in Barrett's esophagus and esophageal adenocarcinoma (EAC). We evaluated 101 archival specimens from patients with EAC as well as seven and 26 samples from patients with high-and low-grade dysplasia, respectively. In addition, normal esophageal squamous epithelium, gastric, and intestinal metaplasia were analyzed when present. The expression patterns of isozymes were detected by immunohistochemistry. CAII and CIX expression levels were lower in the squamous epithelium than in the columnar cells while CAXII showed an opposite pattern and was present mainly in squamous epithelium. Expression patterns in benign, dysplastic, or malignant esophageal columnar lesions were not significantly different. The assessment of clinicopathological associations showed that CAII was significantly downregulated in metastatic disease (p = 0.026). CAIX showed no association with prognosis, although there appeared to be an association (p = 0.056) between high expression and nodal spread. In conclusion, CAII, CAIX, and CAXII do not serve as biomarkers for different phases in the development of EAC.
- Published
- 2018
- Full Text
- View/download PDF
39. Tumour-stroma ratio and prognosis in gastric adenocarcinoma.
- Author
-
Kemi N, Eskuri M, Herva A, Leppänen J, Huhta H, Helminen O, Saarnio J, Karttunen TJ, and Kauppila JH
- Subjects
- Adenocarcinoma pathology, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Mortality, Prognosis, Retrospective Studies, Stomach Neoplasms pathology, Stromal Cells cytology, Survival Analysis, Treatment Outcome, Tumor Microenvironment, Adenocarcinoma mortality, Adenocarcinoma surgery, Stomach Neoplasms mortality, Stomach Neoplasms surgery
- Abstract
Background: Tumour microenvironment, including tumour-stroma ratio (TSR), might help identifying high-risk cancer patients. However, the significance of TSR in gastric cancer is unclear, especially in the intestinal and diffuse subtypes. The aim of this study was to investigate the tumour-stroma ratio in gastric adenocarcinoma, and its intestinal and diffuse histological subtypes, in relation to prognosis., Methods: Five hundred and eighty-three gastric adenocarcinoma patients who underwent surgery in Oulu University hospital during years 1983-2016 were included in this retrospective cohort study. TSR was analysed from the slides that were originally used for diagnostic purposes. Patients were divided into stroma-poor (≤50% stroma) and stroma-rich (>50% stroma) groups and TSR was analysed in relation to 5-year mortality and overall mortality., Results: Patients with stroma-rich tumours had worse 5-year prognosis (HR 1.80, 95% CI 1.41-2.28) compared to stroma-poor tumours. Stratified analysis showed that stroma-rich tumours had worse 5-year prognosis in both intestinal (HR 1.68, 95% CI 1.24-2.27) and diffuse histological types (HR 2.09, 95% CI 1.35-3.23) compared to stroma-poor tumours, respectively., Conclusions: High proportion of stroma is an independent prognostic factor in both intestinal and diffuse histological subtypes of gastric adenocarcinoma.
- Published
- 2018
- Full Text
- View/download PDF
40. Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma.
- Author
-
Leppänen J, Helminen O, Huhta H, Kauppila JH, Isohookana J, Haapasaari KM, Parkkila S, Saarnio J, Lehenkari PP, and Karttunen TJ
- Subjects
- Adenocarcinoma diagnosis, Adenocarcinoma metabolism, Adult, Aged, Carbonic Anhydrase IX metabolism, Female, Finland, Humans, Immunohistochemistry, Male, Middle Aged, Prognosis, Biomarkers, Tumor metabolism, Carcinoma, Pancreatic Ductal diagnosis, Carcinoma, Pancreatic Ductal metabolism, Hypoxia-Inducible Factor 1, alpha Subunit metabolism
- Abstract
Background: HIF-1alpha and CAIX proteins are commonly expressed under hypoxic conditions, but other regulatory factors have been described as well. Pancreatic ductal adenocarcinoma (PDAC) is characterized by hypoxia and strong stromal reaction and has a dismal prognosis with the currently available treatment modalities., Methods: We investigated the expression and prognostic role of HIF-1alpha and CAIX in PDAC series from Northern Finland (n = 69) using immunohistochemistry., Results: In our PDAC cases, 95 and 85% showed HIF-1alpha and CAIX expression, respectively. Low HIF-1alpha expression correlated with poor prognosis, and multivariate analysis identified weak HIF-1alpha intensity as an independent prognostic factor for PDAC-specific deaths (HR 2.176, 95% CI 1.216-3.893; p = 0.009). There was no correlation between HIF-1alpha and CAIX expression levels, and the latter did not relate with survival., Conclusions: Our findings are in contrast with previous research by finding an association between low HIF-1alpha and poor prognosis. The biological mechanisms remain speculative, but such an unexpected relation with prognosis and absence of correlation between HIF-1alpha and CAIX suggests that the prognostic association of HIF-1alpha may not directly be linked with hypoxia. Accordingly, the role of HIF-1alpha might be more complex than previously thought and the use of this marker as a hypoxia-related prognostic factor should be addressed with caution.
- Published
- 2018
- Full Text
- View/download PDF
41. High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer.
- Author
-
Sirniö P, Tuomisto A, Tervahartiala T, Sorsa T, Klintrup K, Karhu T, Herzig KH, Mäkelä J, Karttunen TJ, Salo T, Mäkinen MJ, and Väyrynen JP
- Subjects
- Aged, C-Reactive Protein metabolism, Colorectal Neoplasms genetics, Colorectal Neoplasms pathology, Disease-Free Survival, Female, Humans, Inflammation pathology, Interleukin 1 Receptor Antagonist Protein blood, Interleukin-7 blood, Interleukin-8 blood, Male, Middle Aged, Neutrophils pathology, Prognosis, Proto-Oncogene Proteins B-raf genetics, Biomarkers, Tumor blood, Colorectal Neoplasms blood, Inflammation blood, Matrix Metalloproteinase 8 blood
- Abstract
Background: Matrix metalloproteinase-8 (MMP-8) is a protease mainly expressed by neutrophils that cleaves numerous substrates, including collagens and cytokines. We have previously shown that serum MMP-8 levels increase in colorectal cancer (CRC) and correlate with distant metastasis. However, short follow-up in our prospective cohort did not enable survival analyses at the time of the first publication., Methods: Preoperative serum MMP-8 levels were measured by immunofluorometric assay in 271 CRC patients and related to clinicopathological parameters, markers of systemic inflammation (modified Glasgow Prognostic Score, mGPS; serum levels of C-reactive protein (CRP), albumin and 13 cytokines), the density of six types of tumour-infiltrating immune cells and survival., Results: Increased MMP-8 levels associated with higher mGPS and higher serum levels of CRP and several cytokines, including IL-1ra, IL-7 and IL-8 (p < 0.001 for all). Serum MMP-8 negatively correlated with tumour-infiltrating mast cells (invasive margin: p = 0.005, tumour centre: p = 0.010). The patients with high-serum MMP-8 levels (>100 ng/mL) had poor cancer-specific survival, independent of tumour stage, grade, lymphatic invasion, patient age, BRAF VE1 immunohistochemistry, mismatch repair deficiency, Immunoscore and mGPS (multivariate HR 2.12, 95% CI 1.21-3.71, p = 0.009)., Conclusions: High-serum MMP-8 levels are associated with systemic inflammation and adverse outcome in CRC.
- Published
- 2018
- Full Text
- View/download PDF
42. Micropapillary Structures in Colorectal Cancer: An Anoikis-resistant Subpopulation.
- Author
-
Patankar M, Väyrynen S, Tuomisto A, Mäkinen M, Eskelinen S, and Karttunen TJ
- Subjects
- Adult, Aged, Aged, 80 and over, Anoikis, Female, Humans, Male, Middle Aged, Adenocarcinoma pathology, Colorectal Neoplasms pathology
- Abstract
Background/aim: Micropapillary structures (MIPs) are focal piles of columnar cells without extracellular matrix contact, and common in serrated colorectal carcinoma (CRC). In order to characterize biology of MIPs in colorectal cancer (CRC), the proliferation and apoptosis rates, and survivin expression were compared between MIPs and other cancer epithelial cells of CRC (non-MIPs)., Materials and Methods: We assessed 46 samples of normal colorectal mucosa, 62 carcinomas and 54 polyps for proliferation (Ki67), apoptosis (M30), and survivin expression by immunohistochemistry., Results: MIPs in carcinoma showed lower rates of proliferation and apoptosis than non-MIPs. A low rate of apotosis in MIPs was associated with poor prognosis in local carcinoma. In normal crypts, nuclear-to-cytoplasmic transition of survivin indicated epithelial cell maturation. Cancer cases showed increased cytoplasmic expression of survivin than normal mucosa and polyps. However, MIPs showed lower nuclear and cytoplasmic survivin expression than non-MIPs. Our findings suggest that MIPs represent a biologically distinct subpopulation of carcinoma cells with features of anoikis resistance and possibly quiescence., (Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
43. Preoperative anemia in colorectal cancer: relationships with tumor characteristics, systemic inflammation, and survival.
- Author
-
Väyrynen JP, Tuomisto A, Väyrynen SA, Klintrup K, Karhu T, Mäkelä J, Herzig KH, Karttunen TJ, and Mäkinen MJ
- Subjects
- Aged, Aged, 80 and over, Anemia diagnosis, Biomarkers, Colorectal Neoplasms diagnosis, Colorectal Neoplasms mortality, Colorectal Neoplasms therapy, Combined Modality Therapy, Female, Humans, Inflammation complications, Male, Middle Aged, Neoplasm Grading, Neoplasm Metastasis, Neoplasm Staging, Preoperative Period, Prognosis, Anemia etiology, Colorectal Neoplasms complications
- Abstract
Anemia is common in colorectal cancer (CRC) but its relationships with tumor characteristics, systemic inflammation, and survival have not been well characterized. In this study, blood hemoglobin levels and erythrocyte mean corpuscular volume (MCV) levels were measured in two independent cohorts of 148 CRC patients and 208 CRC patients, and their correlation with patient and tumor characteristics, systemic inflammatory markers (modified Glasgow Prognostic Score: mGPS; serum levels of thirteen cytokines, C-reactive protein, albumin), and survival were analyzed. We found that anemia, most frequently normocytic, followed by microcytic, was present in 43% of the patients. Microcytic anemia was most commonly associated with proximal colon tumor location. Average MCV and blood hemoglobin levels were lower in tumors with high T-class. Low blood hemoglobin associated with systemic inflammation, including high mGPS and high serum levels of C-reactive protein and IL-8. Particularly, normocytic anemia associated with higher mGPS. Normocytic anemia associated with a tendency towards worse overall survival (multivariate hazard ratio 1.61, 95% confidence interval 1.07-2.42, p = 0.023; borderline statistical significance considering multiple hypothesis testing). In conclusion, anemia in CRC patients is most frequently normocytic. Proximal tumor location is associated with predominantly microcytic anemia and systemic inflammation is associated with normocytic anemia.
- Published
- 2018
- Full Text
- View/download PDF
44. Colon epithelial injury in critically ill colectomized patients: aberration of tight junction proteins and Toll-like receptors.
- Author
-
Sipola S, Ala-Kokko TI, Laurila JJ, Saarnio J, Ohtonen P, Syrjälä H, and Karttunen TJ
- Subjects
- Aged, Colon metabolism, Colon pathology, Critical Illness, Female, Humans, Male, Colectomy, Intestinal Mucosa metabolism, Intestinal Mucosa pathology, Tight Junction Proteins biosynthesis, Toll-Like Receptors biosynthesis
- Abstract
Background: Abnormal permeability and extensive epithelial injury are characteristic of colon wall damage complicating critical illness, such as sepsis, and associated with mortality. To assess mechanisms of such colon epithelial disruption, we studied expression of markers of innate immunity and intercellular junctions in patients with critical illness., Methods: Emergency colectomy samples from 38 intensive care unit patients with sepsis, fulminant C. difficile colitis, or colon ischemia were studied. Expression of tight junction proteins (claudin‑1, claudin‑2, occludin) and Toll-like receptors (TLRs) (TLR2, TLR4, TLR5, and TLR9) was studied in samples representing histologically verified damaged segments of the colon, and compared with normal colon (N.=28)., Results: As compared with normal epithelium, histologically damaged samples showed decreased claudin‑1 (P=0.002) expression. Expression of TLR2, TLR4, and TLR5 was similar in patients and controls, but TLR9 expression was up-regulated in the histologically damaged region (P=0.03). The expression of other markers (claudin‑1, claudin‑2, occludin, TLR2,TLR4, TLR5 and TLR9) did not differ between survivors and non-survivors., Conclusions: Down-regulation of claudin‑1 and up-regulation of TLR9 suggest that epithelial barrier dysfunction and innate immunity activation are involved in the pathogenesis of colon epithelial injury in patients with critical illness.
- Published
- 2017
- Full Text
- View/download PDF
45. Divergent expression of bacterial wall sensing Toll-like receptors 2 and 4 in colorectal cancer.
- Author
-
Paarnio K, Väyrynen S, Klintrup K, Ohtonen P, Mäkinen MJ, Mäkelä J, and Karttunen TJ
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma mortality, Colorectal Neoplasms mortality, Disease Progression, Female, Finland epidemiology, Humans, Intestinal Mucosa metabolism, Male, Middle Aged, Carcinoma metabolism, Colorectal Neoplasms metabolism, Toll-Like Receptor 2 metabolism, Toll-Like Receptor 4 metabolism
- Abstract
Aim: To characterize the expression of toll-like receptors (TLR) 2 and 4 in colorectal cancer (CRC) and in normal colorectal mucosa., Methods: We analysed tissue samples from a prospective series of 118 unselected surgically treated patients with CRC. Sections from formalin fixed, paraffin embedded specimens were analysed for TLR2 and TLR4 expression by immunohistochemistry. Two independent assessors evaluated separately expression at the normal mucosa, at the invasive front and the bulk of the carcinoma, and in the lymph node metastases when present. Expression levels in different locations were compared and their associations with clinicopathological features including TNM-stage and the grade of the tumour and 5-year follow-up observations were analysed., Results: Normal colorectal epithelium showed a gradient of expression of both TLR2 and TLR4 with low levels in the crypt bases and high levels in the surface. In CRC, expression of both TLRs was present in all cases and in the major proportion of tumour cells. Compared to normal epithelium, TLR4 expression was significantly weaker but TLR2 expression stronger in carcinoma cells. Weak TLR4 expression in the invasive front was associated with distant metastases and worse cancer-specific survival at 5 years. In tumours of the proximal colon the cancer-specific survival at 5 years was 36.9% better with strong TLR4 expression as compared with those with weak expression ( P = 0.044). In contrast, TLR2 expression levels were not associated with prognosis. Tumour cells in the lymph node metastases showed higher TLR4 expression and lower TLR2 expression than cells in primary tumours., Conclusion: Tumour cells in CRC show downregulation of TLR4 and upregulation of TLR2. Low expression of TLR4 in the invasive front predicts poor prognosis and metastatic disease., Competing Interests: Conflict-of-interest statement: The authors declare that they have no conflict of interest.
- Published
- 2017
- Full Text
- View/download PDF
46. Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer.
- Author
-
Sirniö P, Väyrynen JP, Klintrup K, Mäkelä J, Mäkinen MJ, Karttunen TJ, and Tuomisto A
- Subjects
- Aged, Apolipoproteins B blood, Colorectal Neoplasms complications, Colorectal Neoplasms diagnosis, Female, Humans, Male, Middle Aged, Neoplasm Grading, Prognosis, Serum chemistry, Survival Analysis, Apolipoprotein A-I blood, Colorectal Neoplasms mortality, Colorectal Neoplasms pathology, Systemic Inflammatory Response Syndrome mortality, Systemic Inflammatory Response Syndrome pathology
- Abstract
Recent studies have reported of an association between high serum apolipoprotein A1 (APOA1) levels and favorable prognosis in several malignancies, while the significance of apolipoprotein B (APOB) in cancer is less well-known. In this study, we analyzed the correlation between serum APOA1 and APOB levels, and APOB/APOA1 ratio, and their associations with clinicopathologic parameters, the levels of twenty systemic inflammatory markers, and survival in 144 colorectal cancer (CRC) patients. We demonstrated that low serum APOA1 levels associated with advanced T-class and TNM-stage but low serum APOB levels did not significantly correlate with tumor characteristics. Serum APOA1 levels showed strong negative correlation with the markers of systemic inflammation including serum CRP and interleukin (IL)-8 levels and blood neutrophil count, whereas high serum APOB levels associated with high serum CCL2 levels. High APOA1 and APOB levels and low APOB/APOA1 ratio associated with improved cancer specific and overall survival. APOA1 had independent prognostic value in Cox regression analysis. In conclusion, low serum APOA1 levels are associated with advanced stage and systemic inflammation, while serum APOB does not significantly correlate with tumor stage. Serum APOA1 represents a promising additional prognostic parameter in CRC.
- Published
- 2017
- Full Text
- View/download PDF
47. Tenascin-C and fibronectin in normal esophageal mucosa, Barrett's esophagus, dysplasia and adenocarcinoma.
- Author
-
Leppänen J, Bogdanoff S, Lehenkari PP, Saarnio J, Kauppila JH, Karttunen TJ, Huhta H, and Helminen O
- Abstract
Background: Tenascin-C and fibronectin are adhesive glycoproteins modulating the structure of the extracellular matrix and cellular functions. Their expression and function in esophageal adenocarcinoma is poorly known. The aim of this study was to evaluate the expression of tenascin-C and fibronectin in esophageal adenocarcinoma and its precursor stages., Results: Stromal tenascin-C and fibronectin expression were found in all evaluated lesion types. Expression of both molecules increased from gastric metaplasia towards adenocarcinoma (p<0.05). In carcinomas, tenascin-C expression in the bulk was associated with T-stage (p=0.006), presence of lymph node (p=0.004) and distant organ metastases (p=0.007). Abundant tenascin-C expression associated with poor survival (p=0.034) in univariate analysis. Fibronectin expression associated to T-stage (p=0.030). Expression of tenascin-C or fibronectin in the tumor invasive front was not associated to clinicopathological variables or survival. No significant correlation with tumor/stroma percentage, cancer-associated fibroblasts or mean vascular density was observed with either tenascin-C or fibronectin., Methods: Tenascin-C and fibronectin were stained immunohistochemically and assessed in esophageal specimens from patients with esophageal adenocarcinoma (n=90) or dysplasia (n=30). Structures and lesion were evaluated including normal esophagus (n=77), gastric (n=61) or intestinal (n=51) metaplasia without dysplasia, and low-grade (n=42) or high-grade (n=34) dysplasia, and esophageal adenocarcinoma (n=90). In carcinomas, both bulk and invasive front were separately evaluated. In addition, tumor/stroma percentage, cancer-associated fibroblasts and mean vascular density were evaluated., Conclusions: Tenascin-C and fibronectin are upregulated in esophageal adenocarcinoma when compared to Barrett's esophagus and dysplasia. Increased tenascin-C expression is associated with metastasis and poor prognosis in esophageal adenocarcinoma., Competing Interests: CONFLICTS OF INTEREST The authors state no potential conflicts of interest.
- Published
- 2017
- Full Text
- View/download PDF
48. Intratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma.
- Author
-
Huhta H, Helminen O, Palomäki S, Kauppila JH, Saarnio J, Lehenkari PP, and Karttunen TJ
- Subjects
- Adenocarcinoma pathology, Adult, Aged, Aged, 80 and over, Barrett Esophagus pathology, Electron Transport Complex IV, Esophageal Neoplasms pathology, Female, Humans, Male, Middle Aged, Monocarboxylic Acid Transporters metabolism, Muscle Proteins metabolism, Survival Analysis, Symporters metabolism, Adenocarcinoma metabolism, Barrett Esophagus metabolism, Esophageal Neoplasms metabolism, Lactates metabolism
- Abstract
Background: Monocarboxylate transporters (MCTs) are cell membrane proteins which transport pyruvate, lactate and ketone bodies across the plasma membrane. MCTs are activated in various cancers, but their expression in esophageal adenocarcinoma is not known. The present study was conducted to elucidate the expression of MCTs in esophageal adenocarcinoma and its precursor lesions., Results: Cytoplasmic MCT1, MCT4 and MTCO1 expression linearly increased from normal epithelium to Barrett's mucosa to dysplasia and cancer. Low cytoplasmic MCT1 expression associated with high T-class (P < 0.01), positive lymph node metastases (P < 0.05), positive distant metastases (P < 0.01) and high tumor stage (P < 0.01). High cytoplasmic MCT4 expression correlated significantly with positive distant metastases (P < 0.05). Both low MCT1 and high MCT4 histoscore predicted survival in univariate analysis (P < 0.01). MCT4 histoscore predicted survival in multivariate analysis (P = 0.043; HR 1.8 95%CI 1.0-3.1). MTCO1 expression was not correlated to clinicopathological variables or survival., Materials and Methods: MCT1, MCT4 and mitochondrial cytochrome c oxidase (MTCO1) expression were determined with immunohistochemistry in esophageal specimens from 129 patients with columnar dysplasia or adenocarcinoma. Specimens including normal esophagus (n = 88), gastric (n = 67) or intestinal metaplasia (n = 51), low-grade (n = 42), high-grade dysplasia (n = 37) and esophageal adenocarcinoma (n = 99) were evaluated., Conclusions: Major increase in markers of tumor metabolism occurs during carcinogenesis and progression of esophageal adenocarcinoma. MCT1 and MCT4 are prognostic factors in esophageal adenocarcinoma.
- Published
- 2017
- Full Text
- View/download PDF
49. High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients.
- Author
-
Leppänen J, Helminen O, Huhta H, Kauppila JH, Isohookana J, Haapasaari KM, Lehenkari P, Saarnio J, and Karttunen TJ
- Subjects
- Adult, Aged, Carcinoma, Pancreatic Ductal mortality, Carcinoma, Pancreatic Ductal surgery, Female, Humans, Immunohistochemistry, Kaplan-Meier Estimate, Male, Middle Aged, Pancreatic Neoplasms mortality, Pancreatic Neoplasms surgery, Prognosis, Proportional Hazards Models, Toll-Like Receptor 9 analysis, Biomarkers, Tumor analysis, Carcinoma, Pancreatic Ductal pathology, Pancreatic Neoplasms pathology, Toll-Like Receptor 9 biosynthesis
- Abstract
Pancreatic cancer remains one of the deadliest malignancies in the world. Inflammatory response and tumor environment are thought to play a major role in its pathogenesis. Knowledge on TLR expression and impact on patient survival in pancreatic cancer is limited. The study's aim was to clarify the role of different TLRs in pancreatic cancer. TLR2, TLR4, and TLR9 expression was investigated in 65 surgically resected pancreatic ductal adenocarcinoma specimens by immunohistochemistry. The association between TLR expression, clinical parameters, and local inflammatory response to the tumor was assessed using chi-square test. Relation between patient survival and TLR expression was calculated with multivariable Cox regression, adjusted for age, sex, and tumor stage. We found TLR2, TLR4, and TLR9 to be expressed in pancreatic cancer. There was no association between TLR expression and tumor stage, tumor size, lymph node metastasis, or tumor necrosis. Contrary to our initial hypothesis, high cytoplasmic TLR9 expression was associated with longer patient survival, and multivariate analysis identified low TLR9 expression as an independent risk factor for cancer-specific death (HR 3.090, 95% CI 1.673-5.706). The results suggest that high TLR9 expression in pancreatic ductal adenocarcinoma indicates improved prognosis. The prognostic effect of TLR9 might be associated with bacterial exposure, but this needs further evidence.
- Published
- 2017
- Full Text
- View/download PDF
50. Localization of nucleic acid-sensing toll-like receptors in human and mouse pancreas.
- Author
-
Helminen O, Huhta H, Kauppila JH, Lehenkari PP, Saarnio J, and Karttunen TJ
- Subjects
- Animals, Female, Glucagon analysis, Humans, Immunohistochemistry, Insulin analysis, Male, Mice, Somatostatin analysis, Islets of Langerhans chemistry, Islets of Langerhans immunology, Nucleic Acids metabolism, Toll-Like Receptors analysis
- Abstract
Nucleic acid-sensing toll-like receptors (TLRs) (3, 7, 8, 9) have a role both in antiviral innate immunity and in autoimmune disorders. We assessed the expression of TLR3, 7, 8 and 9 in human and mouse pancreas focusing on the subpopulations of cells in the Langerhans islets. We studied eight human samples with normal pancreatic islets and two samples from patients with type 1 diabetes. Additionally, 10 CD-1 mouse pancreases were analysed. Immunohistochemical double-stainings for the TLRs and insulin, glucagon or somatostatin, respectively, were performed along with appropriate controls. In human pancreas, strong immunoreaction of TLR7 and TLR8 was observed in the insulin-positive beta cells, whereas glucagon- or somatostatin-expressing cells of the islets were weakly stained or negative. In type 1 diabetes, the expression in islets was weak or lost (TLR7: p = 0.014, TLR8: p = 0.053), correlating with loss of beta cells. TLR3 and 9 were expressed only weakly with no correlation with specific cell types. In mouse pancreas, only TLR9 was detected. Intra-pancreatic nerve ganglia strongly expressed TLR7. The strong expression of TLR7 and TLR8 in the beta cells of normal human islets could be an important piece in the puzzle of type 1 diabetes pathogenesis, and be linked with destruction of this particular subpopulation of the islet cells. In normal mice, only TLR9 can be constantly detected in the islets, highlighting differences between the species., (© 2016 APMIS. Published by John Wiley & Sons Ltd.)
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.